Focus Taiwan App

SARS antibody could lead to rapid testing for COVID-19: NHRI

02/27/2020 06:15 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

A SARS antibody could be used to develop a rapid diagnostic test for the coronavirus responsible for COVID-19, National Health Research Institutes (NHRI) Vice President Sytwu Huey-kang (司徒惠康) said Wednesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

    We value your privacy.
    Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.